Showing results (71-80 of 65,891) with videos related to
Sort By:
Pageof 6,590
Expert Review of Clinical Pharmacology|June 30, 2020
The role of triple therapy in the management of COPDLuigino Calzetta, Maria Gabriella Matera, Paola Rogliani, et al.Expert Opinion on Drug Safety|May 30, 2024
An overview of the efficacy and safety of β2-adrenoceptor antagonists for the treatment of chronic obstructive pulmonary diseaseMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.International Journal of Chronic Obstructive Pulmonary Disease|November 28, 2024
Emerging Anti-Inflammatory COPD Treatments: Potential Cardiovascular ImpactsMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.Expert Opinion on Drug Discovery|April 23, 2014
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyondLuigino Calzetta, Paola Rogliani, Mario Cazzola, et al.Expert Opinion on Drug Discovery|May 13, 2016
The discovery of roflumilast for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.Drug Safety|March 1, 2016
Safety Considerations with Dual Bronchodilator Therapy in COPD: An UpdateMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.Expert Review of Clinical Pharmacology|December 3, 2024
The need for inhaled phosphodiesterase inhibitors in chronic obstructive pulmonary diseaseMario Cazzola, Luigino Calzetta, Paola Rogliani, et al.Drugs|February 21, 2020
TSLP Inhibitors for Asthma: Current Status and Future ProspectsMaria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.Science Advances|December 10, 2020
Mus81-Eme1-dependent aberrant processing of DNA replication intermediates in mitosis impairs genome integrityNicolás Luis Calzetta, Marina Alejandra González Besteiro, Vanesa GottifrediRespiratory Medicine|May 29, 2019
Monoclonal antibodies for severe asthma: Pharmacokinetic profilesMaria Gabriella Matera, Luigino Calzetta, Paola Rogliani, et al.Pageof 6,590